BioNexus Gene Lab Corp (NASDAQ: BGLC)
$0.52
-0.0104 ( -1.96% ) 40.0K
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
Market Data
Open
$0.52
Previous close
$0.53
Volume
40.0K
Market cap
$9.36M
Day range
$0.48 - $0.53
52 week range
$0.31 - $16.20
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Apr 01, 2024 |
nt | Quarterly Reports | 1 | Mar 28, 2024 |
10-q/a | Quarterly Reports | 65 | Mar 26, 2024 |
def | Proxies and info statements | 1 | Feb 29, 2024 |
pre | Proxies and info statements | 1 | Jan 26, 2024 |
10-q | Quarterly Reports | 5 | Nov 20, 2023 |
nt | Quarterly Reports | 1 | Nov 14, 2023 |
8-k | 8K-related | 14 | Nov 13, 2023 |
8-k | 8K-related | 14 | Nov 03, 2023 |
8-k/a | 8K-related | 14 | Oct 30, 2023 |